Adam M Staffaroni
Overview
Explore the profile of Adam M Staffaroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morrow C, Kamath V, Dickerson B, Eldaief M, Rezaii N, Wong B, et al.
Psychiatry Clin Neurosci
. 2025 Mar;
PMID: 40079430
Aim: Cognitive and behavioral phenomena define behavioral variant frontotemporal dementia (bvFTD), but neuropsychiatric symptoms (NPS) outside the core criteria are common throughout the illness. Identifying how NPS cluster in bvFTD...
2.
Rajbanshi B, Prufer Q C Araujo I, VandeVrede L, Ljubenkov P, Staffaroni A, Heuer H, et al.
Alzheimers Dement (Amst)
. 2025 Jan;
17(1):e70078.
PMID: 39886325
Introduction: Plasma amyloid beta/amyloid beta (Aβ/Aβ) and phosphorylated tau217 (p-tau217) identify individuals with primary Alzheimer's disease (AD). They may detect AD co-pathology in the setting of other primary neurodegenerative diseases,...
3.
Casaletto K, Saloner R, Kornak J, Staffaroni A, Villeda S, Paolillo E, et al.
Brain Commun
. 2025 Jan;
7(1):fcae432.
PMID: 39816189
The largest risk factor for dementia is age. Heterochronic blood exchange studies have uncovered age-related blood factors that demonstrate 'pro-aging' or 'pro-youthful' effects on the mouse brain. The clinical relevance...
4.
Torres-Espin A, Radabaugh H, Treiman S, Fitzsimons S, Harvey D, Chou A, et al.
Sci Transl Med
. 2024 Nov;
16(775):eadk3118.
PMID: 39602511
Aberrant angiogenesis could contribute to the development of cognitive impairment and represent a therapeutic target for preventing dementia. However, most studies addressing angiogenesis and cognitive impairment focus on model organisms....
5.
Luckey A, Ghosh S, Wang C, Beiser A, Bernal R, Li Z, et al.
Alzheimers Dement
. 2024 Nov;
20(12):8814-8824.
PMID: 39569745
Background: Peak-width of skeletonized mean diffusivity (PSMD), a neuroimaging marker of cerebral small vessel disease (SVD), has shown excellent instrumental properties. Here, we extend our work to perform a biological...
6.
Li L, Staffaroni A, Whitlock E
Adv Anesth
. 2024 Oct;
42(1):27-40.
PMID: 39443048
Postoperative cognitive recovery is deeply important to patients and perioperative clinicians. Despite decades of data on "postoperative cognitive decline" (POCD), a research diagnosis based on objective cognitive test performance, perspectives...
7.
Morrow C, Kamath V, Dickerson B, Eldaief M, Rezaii N, Wong B, et al.
medRxiv
. 2024 Oct;
PMID: 39398998
Objectives: Cognitive and behavioral phenomena define behavioral variant frontotemporal dementia (bvFTD), but neuropsychiatric symptoms (NPS) outside the core criteria are common throughout the illness. Identifying how NPS cluster in bvFTD...
8.
Vandebergh M, Ramos E, Corriveau-Lecavalier N, Ramanan V, Kornak J, Mester C, et al.
Neurology
. 2024 Sep;
103(8):e209832.
PMID: 39321401
Background And Objectives: has been proposed as a modifier of disease risk in FTLD-TDP, particularly in pathogenic variant carriers. Furthermore, has been investigated as a disease modifier in the context...
9.
Feldman H, Cummings J, Boxer A, Staffaroni A, Knopman D, Sukoff Rizzo S, et al.
Alzheimers Dement
. 2024 Sep;
20(11):8129-8152.
PMID: 39316411
The tauopathies are defined by pathological tau protein aggregates within a spectrum of clinically heterogeneous neurodegenerative diseases. The primary tauopathies meet the definition of rare diseases in the United States....
10.
VandeBunte A, Lee H, Paolillo E, Hsiung G, Staffaroni A, Saloner R, et al.
Alzheimers Dement
. 2024 Sep;
20(10):6820-6833.
PMID: 39240048
Introduction: Cardiovascular health is important for brain aging, yet its role in the clinical manifestation of autosomal dominant or atypical forms of dementia has not been fully elucidated. We examined...